<DOC>
	<DOCNO>NCT02919709</DOCNO>
	<brief_summary>The study aim investigate existence reliable correlation progression aortic diameter blood level circulant endothelial progenitor cell CD34+ patient surgical aortic aneurysm .</brief_summary>
	<brief_title>Follow Patients With Aortic Aneurysm Dosage Circulant Endothelial Progenitor Cells</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<criteria>1 . Patients age 18 . 2 . Patients diagnose thoracic abdominal aortic aneurysm indication surgical treatment ( diameter &gt; 30 mm &lt; 50 mm ) . 3 . Patients accept sign specific inform consent . 1 . Unstable coronary artery disease . 2 . Congenital heart disease . 3 . Any evolve infectious syndrome viral infection ( HIV , HBV HCV ) . 4 . Any chronic inflammatory autoimmune disease . 5 . Prior administration GCSF ; EPO ; GMCSF . 6 . Liver failure . 7 . Prior oncologic disease ongoing cancer life expectancy &lt; 1 year . 8 . Dementia . 9 . Pregnancy . 10 . Patients age &lt; 18 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>